| Eligibility |
| Age-lower limit |
|
| Age-upper limit |
|
| Gender |
Male and Female |
| Key inclusion criteria |
1. Patient is at least 18 years of age and signed Informed Consent
2. Subject has coronary artery disease involving a bifurcation with objective evidence of ischemia including patients with chronic stable angina, silent ischemia and NSTE-ACS
3. Subject is appropriate to be treated by PCI according to the local practice (operator's judgment or heart team decision)
4. Patients residence is in the area covered by the hospital
5. Patients with angiographically significant stenosis (>50 % by visual assessment) in de novo, native, previously unstented bifurcation lesion(s) including left main lesion, which is in operator's opinion appropriate to be treated by PCI with a single stent strategy
6. The size of main vessel matches available Ultimaster stent sizes (<4.0 mm, and 2.0 mm by visual assessment).
7. The size of side branch is >2.0mm in diameter by visual assessment.
8. The sidebranch is treatable with a sidebranch fenestration and/or kissing balloon
|
| Key exclusion criteria |
1. Pregnancy
2. Patients with ST elevation myocardial infarction
3. Known intolerance to aspirin, clopidogrel, heparin, cobalt chromium, sirolimus, contrast material
4. Known thrombocytopenia (platelet count< 100,000/mm3)
5. Cardiogenic Shock
6. Significant comorbidities precluding clinical follow-up (as judged by investigators)
7. Major planned surgery that requires discontinuation of dual antiplatelet therapy
8. History of stenting in the target bifurcation lesion
9. Renal insufficiency (GFR/MDRD <45 ml/min), which precludes in operator's opinion contrast injection during repeat OFDI pullback
10. Severely tortuous or angulated coronary anatomy of the study vessel that in the opinion of the investigator would result in sub-optimal optical frequency domain imaging (OFDI) or excessive risk of complication to place an OFDI catheter.
11. Target lesion reference vessel diameter (RVD) < 2.25 and > 4 mm
12. Others, Patient judged inappropriate by the attending physician
|
| Target sample size |
106 |
| Result |
| URL related to results and publications |
https://pubmed.ncbi.nlm.nih.gov/33272034/ |
| Number of participants that the trial has enrolled |
110 |
| Results |
a primary endpoint was significantly reduced by about 30% in the OFDI arm, and the metallic carina in the bifurcation was significantly less frequently observed in the OFDI arm .
The feasibility of 3D-OFDI was considerably high (98%), and approximately 60% of the patients were able to achieve an optimal wire re-crossing in the first attempt. It was finally achieved in all cases in the OFDI arm.
There was no significant difference in radiocontrast volume during the procedure between the two arms. |
| Results date posted |
| 2021 |
Year |
07 |
Month |
30 |
Day |
|
| Results Delayed |
|
| Results Delay Reason |
|
| Date of the first journal publication of results |
|
| Baseline Characteristics |
Mean age was 69 years and approximately half of the patients were DM. ACS was less than 10%, and a vast majority was classified as stable angina. LMT or LAD-Dx (LM 8%) bifurcation was treated in 70% of cases. True bifurcation was observed in 14% of the OFDI arm vs 6% of the Angio arm (p=0.14).
POT was performed in almost all (98%) of the cases. |
| Participant flow |
A total of 106 patients (56 in the OFDI arm and 54 in the Angio arm) were enrolled from October 2016 to March 2018 |
| Adverse events |
There were no device failures or device-related adverse events, but there was 1 bleeding event (subcutaneous hemorrhage at the puncture site [Angio arm]), 12 cardiovascular events including 1 cerebral infarction (OFDI arm), 1 TIA (Angio arm), or 10 unplanned PCIs (7 OFDI arm and 3 Angio arm), and 1 death (OFDI arm).
The main cause of the death was TAVI valve infection and sepsis at 6 weeks after PCI. |
| Outcome measures |
Post-procedural percentage of malapposed struts assessed by OFDI in bifurcation segment of main vessel |
| Plan to share IPD |
|
| IPD sharing Plan description |
|